According to a report, new medicines, medical gadgets, cosmetic bills are currently undergoing inter-ministerial consultation. Due to this, it is being speculated that the government will stop buying medicines online. This new decision can replace the existing Drugs and Cosmetics Act of 1940.
The government now wants to focus on the functioning of online pharmacy. The government also wants to control the misuse of doctor’s prescription so that patient’s data and privacy do not fall into wrong hands. The e-Pharmacy app captures area-wise data related to the consumption of medicines. This can put the safety of the patient at risk. A group of ministers has given its consent regarding this rule.
Some popular pharmacy apps, including Tata 1mg, Amazon, Flipkart, NetMeds, MediBuddy, Practo, and Apollo, received show-cause notices from the Drugs Controller General of India (DCGI) in February. The notice was regarding alleged violation of norms.
Summarize this content to 100 words New Delhi. The government takes many such decisions on the coming days which are very important in terms of our security. Now another such decision has come to the fore, about which the users are a little confused as to why this is being done. Actually, apps like Tat 1mg and Netmeds may be banned soon. Rules and strict action are being considered against online pharmacy. This decision is being taken in view of data privacy, wrong practice and baseless sale of medicines. According to a report, new medicines, medical gadgets, cosmetic bills are currently undergoing inter-ministerial consultation. Due to this, it is being speculated that the government will stop buying medicines online. This new decision can replace the existing Drugs and Cosmetics Act of 1940. The government now wants to focus on the functioning of online pharmacy. The government also wants to control the misuse of doctor’s prescription so that patient’s data and privacy do not fall into wrong hands. The e-Pharmacy app captures area-wise data related to the consumption of medicines. This can put the safety of the patient at risk. A group of ministers has given its consent regarding this rule. Some popular pharmacy apps, including Tata 1mg, Amazon, Flipkart, NetMeds, MediBuddy, Practo, and Apollo, received show-cause notices from the Drugs Controller General of India (DCGI) in February. The notice was regarding alleged violation of norms.
